• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Unravel hepatic artery infusion chemotherapy in patients with resected colorectal liver metastases.

作者信息

Donadon Matteo, Rimassa Lorenza, Torzilli Guido

机构信息

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

Department of Hepatobiliary and General Surgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.

出版信息

Hepatobiliary Surg Nutr. 2021 Apr;10(2):257-260. doi: 10.21037/hbsn-20-832.

DOI:10.21037/hbsn-20-832
PMID:33898571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8050568/
Abstract
摘要

相似文献

1
Unravel hepatic artery infusion chemotherapy in patients with resected colorectal liver metastases.解析肝动脉灌注化疗在切除的结直肠癌肝转移患者中的应用。
Hepatobiliary Surg Nutr. 2021 Apr;10(2):257-260. doi: 10.21037/hbsn-20-832.
2
[Continuous hepatic artery infusion chemotherapy and chemoembolization for treatment of patients with liver metastases from colorectal cancer].持续肝动脉灌注化疗及化疗栓塞术治疗结直肠癌肝转移患者
Ai Zheng. 2002 Apr;21(4):421-3.
3
Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.基础研究推动了不可切除孤立性结直肠癌肝转移化疗的发展，形成了一种采用米托蒽醌、5-氟尿嘧啶+亚叶酸和丝裂霉素C的肝动脉灌注方案。
Gan To Kagaku Ryoho. 1999 Feb;26(3):269-81.
4
Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer.5-氟尿嘧啶与丝裂霉素C动脉化疗治疗结直肠癌肝转移
World J Gastroenterol. 2002 Aug;8(4):663-7. doi: 10.3748/wjg.v8.i4.663.
5
[Treatment of colorectal cancer--hepatic metastases].[结直肠癌肝转移的治疗]
Gan To Kagaku Ryoho. 2002 Nov;29(12):2447-9.
6
Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival.结直肠癌肝转移：手术切除、局部消融和肝动脉灌注泵治疗与生存期延长相关。
Arch Surg. 2001 Mar;136(3):318-23. doi: 10.1001/archsurg.136.3.318.
7
[Management after hepatectomy of colorectal cancer metastases to the liver--intrahepatic arterial infusion chemotherapy and repeated hepatectomy].[结直肠癌肝转移灶肝切除术后的管理——肝动脉内灌注化疗及重复肝切除术]
Gan To Kagaku Ryoho. 1999 Oct;26(12):1747-51.
8
Current role of hepatic artery infusion and isolated liver perfusion for the treatment of colorectal cancer liver metastases.肝动脉灌注和离体肝灌注在结直肠癌肝转移治疗中的当前作用。
Cancer J. 2004 Mar-Apr;10(2):128-38. doi: 10.1097/00130404-200403000-00008.
9
Hepatic artery infusion of chemotherapy as a treatment for hepatic metastases from colorectal cancer.肝动脉灌注化疗作为结直肠癌肝转移的一种治疗方法。
Cancer J. 2002 May-Jun;8 Suppl 1:S82-8.
10
[Clinical trial of prophylactic hepatic arterial chemotherapy for liver metastases in patients with Dukes' C colorectal cancer].[Dukes' C期结直肠癌患者肝转移预防性肝动脉化疗的临床试验]
Gan To Kagaku Ryoho. 1999 Oct;26(12):1690-3.

引用本文的文献

1
Feasibility of Hepatic Artery Infusion Chemotherapy for Colorectal Liver Metastasis in an Indian Setting.肝动脉灌注化疗用于印度环境下结直肠癌肝转移的可行性
Indian J Surg Oncol. 2024 May;15(Suppl 2):275-280. doi: 10.1007/s13193-023-01871-0. Epub 2023 Dec 29.

本文引用的文献

1
Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients.辅助性肝动脉灌注化疗与生存改善相关，与结直肠癌肝转移患者 KRAS 突变状态无关：674 例患者的回顾性分析。
Ann Surg. 2020 Aug;272(2):352-356. doi: 10.1097/SLA.0000000000003248.
2
Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.低危可切除结直肠癌肝转移患者中辅助性肝动脉灌注泵化疗联合切除术与单纯切除术的比较——多中心随机对照 PUMP 试验。
BMC Cancer. 2019 Apr 5;19(1):327. doi: 10.1186/s12885-019-5515-6.
3
Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).结直肠肝转移切除术后高危患者辅助治疗的术后肝动脉化疗-一项随机 II/III 期试验-PACHA-01（NCT02494973）。
BMC Cancer. 2018 Aug 6;18(1):787. doi: 10.1186/s12885-018-4697-7.
4
Cure model survival analysis after hepatic resection for colorectal liver metastases.结直肠癌肝转移肝切除术后的治愈模型生存分析。
Ann Surg Oncol. 2015;22(6):1908-14. doi: 10.1245/s10434-014-4234-0. Epub 2014 Nov 15.
5
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.转移性结直肠癌：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2014 Sep;25 Suppl 3:iii1-9. doi: 10.1093/annonc/mdu260. Epub 2014 Sep 4.
6
Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement.经肝动脉置泵化疗治疗结直肠癌肝转移专家共识。
Curr Oncol. 2014 Feb;21(1):e129-36. doi: 10.3747/co.21.1577.
7
Regional chemotherapy: a focus on hepatic artery infusion for colorectal cancer liver metastases.区域化疗：聚焦于结直肠癌肝转移的肝动脉灌注化疗
Surg Oncol Clin N Am. 2008 Oct;17(4):759-71, viii. doi: 10.1016/j.soc.2008.04.009.
8
Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver.对已切除或消融肝转移结直肠癌的患者进行肝动脉辅助化疗。
Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD003770. doi: 10.1002/14651858.CD003770.pub3.
9
Trends in long-term survival following liver resection for hepatic colorectal metastases.肝结直肠癌转移灶肝切除术后的长期生存趋势。
Ann Surg. 2002 Jun;235(6):759-66. doi: 10.1097/00000658-200206000-00002.
10
Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study.可切除的转移性结直肠癌肝转移联合治疗：肝转移灶手术切除联合持续灌注化疗——一项多组间研究
J Clin Oncol. 2002 Mar 15;20(6):1499-505. doi: 10.1200/JCO.2002.20.6.1499.